Tilaknagar Industries Ltd
Tilaknagar Industries Ltd. is primarily involved in manufacturing and sale of Indian Made Foreign Liquor (IMFL). [1]
- Market Cap ₹ 10,577 Cr.
- Current Price ₹ 508
- High / Low ₹ 550 / 200
- Stock P/E 38.8
- Book Value ₹ 95.6
- Dividend Yield 0.20 %
- ROCE 28.2 %
- ROE 29.6 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 26.4% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 26.6%
Cons
- Promoter holding has decreased over last quarter: -2.77%
- Tax rate seems low
- Working capital days have increased from 61.9 days to 93.8 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 824 | 748 | 458 | 515 | 578 | 661 | 653 | 549 | 783 | 1,164 | 1,394 | 1,434 | 1,554 | |
| 654 | 653 | 580 | 609 | 575 | 605 | 705 | 495 | 671 | 1,027 | 1,208 | 1,179 | 1,260 | |
| Operating Profit | 170 | 95 | -122 | -94 | 3 | 56 | -52 | 54 | 112 | 137 | 185 | 255 | 293 |
| OPM % | 21% | 13% | -27% | -18% | 1% | 8% | -8% | 10% | 14% | 12% | 13% | 18% | 19% |
| 4 | 2 | 3 | 2 | 33 | 5 | 485 | 11 | 24 | 85 | 11 | 18 | 19 | |
| Interest | 64 | 97 | 125 | 157 | 152 | 184 | 129 | 71 | 62 | 40 | 27 | 12 | 10 |
| Depreciation | 25 | 28 | 39 | 38 | 37 | 37 | 33 | 33 | 33 | 32 | 32 | 31 | 30 |
| Profit before tax | 85 | -28 | -283 | -288 | -153 | -160 | 271 | -39 | 41 | 150 | 138 | 230 | 273 |
| Tax % | 31% | 44% | -0% | -3% | -1% | -0% | 1% | -0% | -10% | -0% | 0% | -0% | |
| 58 | -40 | -282 | -280 | -151 | -160 | 270 | -38 | 45 | 150 | 138 | 230 | 272 | |
| EPS in Rs | 4.71 | -3.22 | -22.58 | -22.41 | -12.11 | -12.75 | 21.56 | -3.06 | 2.85 | 8.09 | 7.16 | 11.86 | 13.88 |
| Dividend Payout % | 17% | -2% | 0% | 0% | 0% | 0% | 0% | 0% | 4% | 3% | 7% | 8% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 17% |
| 3 Years: | 22% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 26% |
| 3 Years: | 93% |
| TTM: | 50% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 36% |
| 5 Years: | 96% |
| 3 Years: | 74% |
| 1 Year: | 50% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 27% |
| Last Year: | 30% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 124 | 125 | 125 | 125 | 125 | 125 | 125 | 125 | 159 | 185 | 193 | 194 | 208 |
| Reserves | 459 | 417 | 131 | -104 | -255 | -412 | -143 | -181 | -25 | 298 | 461 | 689 | 1,783 |
| 832 | 825 | 885 | 1,072 | 1,031 | 1,111 | 579 | 702 | 585 | 256 | 121 | 44 | 49 | |
| 250 | 349 | 387 | 258 | 383 | 457 | 519 | 365 | 295 | 273 | 258 | 286 | 290 | |
| Total Liabilities | 1,665 | 1,716 | 1,528 | 1,350 | 1,284 | 1,281 | 1,080 | 1,012 | 1,013 | 1,012 | 1,033 | 1,213 | 2,330 |
| 461 | 608 | 579 | 542 | 587 | 552 | 502 | 469 | 439 | 420 | 396 | 370 | 356 | |
| CWIP | 234 | 123 | 124 | 124 | 113 | 114 | 100 | 100 | 100 | 0 | 0 | 3 | 40 |
| Investments | 2 | 3 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 23 | 12 | 30 | 32 |
| 968 | 982 | 824 | 685 | 583 | 612 | 478 | 443 | 474 | 569 | 625 | 810 | 1,901 | |
| Total Assets | 1,665 | 1,716 | 1,528 | 1,350 | 1,284 | 1,281 | 1,080 | 1,012 | 1,013 | 1,012 | 1,033 | 1,213 | 2,330 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56 | 213 | 13 | 26 | 175 | 91 | 191 | 85 | 65 | 71 | 117 | 178 | |
| -123 | -85 | -3 | -2 | -8 | -3 | 5 | -0 | -26 | -12 | -15 | -77 | |
| 55 | -113 | -27 | -28 | -105 | -104 | -208 | -78 | -41 | -67 | -129 | -94 | |
| Net Cash Flow | -12 | 15 | -17 | -5 | 62 | -17 | -13 | 8 | -2 | -8 | -26 | 7 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 99 | 72 | 91 | 106 | 109 | 133 | 136 | 120 | 110 | 106 | 110 | 104 |
| Inventory Days | 124 | 237 | 134 | 194 | 206 | 252 | 115 | 200 | 144 | 152 | 113 | 191 |
| Days Payable | 68 | 289 | 218 | 365 | 418 | 502 | 298 | 412 | 340 | 169 | 135 | 171 |
| Cash Conversion Cycle | 154 | 21 | 7 | -65 | -103 | -117 | -46 | -91 | -86 | 89 | 87 | 125 |
| Working Capital Days | 38 | 9 | -148 | -441 | -583 | -550 | -12 | -147 | -42 | 16 | 76 | 94 |
| ROCE % | 11% | 5% | -13% | -11% | -0% | 3% | -8% | 5% | 13% | 15% | 22% | 28% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Change in Directorate
7h - Appointed Jenamejayan Kamalam Shivan as Independent Director Nov 13, 2025–Nov 12, 2028, subject to shareholder approval.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
7h - Q2 revenue Rs398 Cr, EBITDA Rs60 Cr, PAT Rs53 Cr; CCI approved Imperial Blue acquisition; completion expected Q3 FY26.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
8h - Earnings Presentation for Unaudited Financial Results for Quarter and Half Year Ended September 30, 2025
- Regulation 30 Of SEBI (LODR) Regulations, 2015 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025 8h
- Regulation 30 Of SEBI (LODR) Regulations, 2015 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025 8h
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Concalls
-
Nov 2025TranscriptNotesPPT
-
Aug 2025Transcript PPT REC
-
Jul 2025TranscriptNotesPPT
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023TranscriptNotesPPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Sep 2021TranscriptNotesPPT
Company Overview[1]
Tilaknagar Industries Ltd. (TI) is an Indian alcoholic beverage company with a diverse portfolio of brands across various segments. The company is known for Mansion House Brandy, the largest-selling brandy in India and the second-largest globally.